Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference37 articles.
1. Managing immune checkpoint-blocking antibody side effects;Postow;Am Soc Clin Oncol Educ Book,2015
2. Toxicities of the anti-PD-1 and anti PD-L1 immune checkpoint antibodies;Naidoo;Ann Oncol,2015
3. Efficacy and safety of nivolumab in patients with BRAF V600 mutant and BRAF wild-type advanced melanoma: a pooled analysis of 4 clinical trials;Larkin;JAMA Oncol,2015
4. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015
5. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N Engl J Med,2015
Cited by 229 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Case report: pathological complete response after S-1/oxaliplatin regimen combined with trastuzumab and tislelizumab in patients with locally advanced gastric cancer;Frontiers in Oncology;2024-09-05
2. Notfälle in der Medikamentösen Tumortherapie;TumorDiagnostik & Therapie;2024-09
3. Disseminate Cutaneous Vasculitis Associated with Durvalumab Treatment—Case Report, Mini-Review on Cutaneous Side Effects of Immune Checkpoint Inhibitor Therapies with Machine Learning Perspectives;Life;2024-08-25
4. Symptom clusters and network analysis of patients with intermediate and advanced liver cancer treated with targeted immunotherapy;Supportive Care in Cancer;2024-08-08
5. The Impact of Immune Checkpoint Inhibitors-Induced Skin Toxicity on Patients’ Quality of Life and the Role of Dermatologic Intervention;Dermatology Practical & Conceptual;2024-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3